Herceptin, Alimta and Remicade batches concerned by ongoing investigation

As announced by the European Medicines Agency (EMA) on 16 and 17 April 2014, national competent authorities are working to identify all concerned batches and put in place appropriate measures to protect the health of EU citizens. In parallel to the investigations, all vials suspected of being affected are being recalled from the EU market.

In addition, Member State authorities are considering temporary measures including quarantine of suspected products or restriction of parallel distribution of the concerned products.

This page lists the batches